Kontour XiAn Medical Technology Co Ltd
SSE:688314
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kontour XiAn Medical Technology Co Ltd
Cash from Operating Activities
Kontour XiAn Medical Technology Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kontour XiAn Medical Technology Co Ltd
SSE:688314
|
Cash from Operating Activities
¥140.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Operating Activities
¥967.8m
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Operating Activities
¥1.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
16%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Operating Activities
¥10.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Cash from Operating Activities
¥257.6m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Operating Activities
-¥619m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kontour XiAn Medical Technology Co Ltd
Glance View
Kontour XiAn Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of Class-III implantable medical device products. The Company's main products include titanium skull repair and fixation products for neurosurgical implantation and poly-ether-ether-ketone (PEEK) skull repair and fixation products, as well as sternum fixation products, neurospine products, supporting implant tools and other products. The Company's main products are used in neurosurgery skull repair fixation and cardiothoracic surgery sternal fixation. The Company distributes its products both in the domestic market and to overseas markets.
See Also
What is Kontour XiAn Medical Technology Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
140.3m
CNY
Based on the financial report for Dec 31, 2024, Kontour XiAn Medical Technology Co Ltd's Cash from Operating Activities amounts to 140.3m CNY.
What is Kontour XiAn Medical Technology Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
19%
Over the last year, the Cash from Operating Activities growth was 65%. The average annual Cash from Operating Activities growth rates for Kontour XiAn Medical Technology Co Ltd have been 11% over the past three years , 19% over the past five years .
